<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00829634</url>
  </required_header>
  <id_info>
    <org_study_id>27.092</org_study_id>
    <nct_id>NCT00829634</nct_id>
  </id_info>
  <brief_title>Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>California Pacific Medical Center Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>San Francisco General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>California Pacific Medical Center Research Institute</source>
  <brief_summary>
    <textblock>
      The intent of this study is to see if the rate that the body breaks down l-methamphetamine
      (l-MA) could be used as an accurate estimate for the rate that the body breaks down
      d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA
      is the commonly abused form of methamphetamine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will screen at St. Luke's Hospital in San Francisco to determine their eligibility.

      Once enrolled the study will take two weeks. During the first week subjects attend daily,
      hour-long outpatient visits at San Francisco General Hospital. At these visits subjects will
      receive an oral dose of l-methamphetamine, have their vitals read, answer questionnaires and
      receive a blood draw.

      During the second week of the study subjects are admitted to San Francisco General Hospital
      for a week long inpatient stay. During this stay the subject continues to receive
      l-methamphetamine but also receives three doses of d-methamphetamine on three separate days.
      In addition the subject receives blood draws, has their urine collected, and answers
      questionnaires.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum samples</measure>
    <time_frame>Predose and Multiple Timepoints Post Doses</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine Samples</measure>
    <time_frame>24 Hour Inpatient Collection</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnaries</measure>
    <time_frame>Predose and Multiple Timepoints Post Doses</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Nasal Congestion</condition>
  <arm_group>
    <arm_group_label>l-methamphetamine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>l-methamphetamine</intervention_name>
    <description>5mg of l-methamphetamine per day throughout the 2 week study</description>
    <arm_group_label>l-methamphetamine</arm_group_label>
    <other_name>l-MA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>d-methamphetamine</intervention_name>
    <description>15mg on Study Day 9, 30mg on Study Day 11, 45mg on Study Day 13</description>
    <arm_group_label>l-methamphetamine</arm_group_label>
    <other_name>d-MA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Males and Females Between the Ages of 18 and 50

          -  Must have some experience with methamphetamine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CPMC Addiction &amp; Pharmacology Research Laboratory (APRL)</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2009</study_first_submitted>
  <study_first_submitted_qc>January 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2009</study_first_posted>
  <last_update_submitted>May 29, 2013</last_update_submitted>
  <last_update_submitted_qc>May 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>California Pacific Medical Center Research Institute</investigator_affiliation>
    <investigator_full_name>John Mendelson, MD</investigator_full_name>
    <investigator_title>Senior Scientist</investigator_title>
  </responsible_party>
  <keyword>methamphetamine</keyword>
  <keyword>inpatient</keyword>
  <keyword>d-MA</keyword>
  <keyword>l-MA</keyword>
  <keyword>APRL</keyword>
  <keyword>San Francisco</keyword>
  <keyword>metabolism</keyword>
  <keyword>Metabolism of methamphetamine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

